Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 589 to 260 of 260 entries
Sorted by: Best Match Show Resources per page
Pituitary society expert Delphi consensus: operative workflow in endoscopic transsphenoidal pituitary adenoma resection.

Pituitary

Marcus HJ, Khan DZ, Borg A, Buchfelder M, Cetas JS, Collins JW, Dorward NL, Fleseriu M, Gurnell M, Javadpour M, Jones PS, Koh CH, Layard Horsfall H, Mamelak AN, Mortini P, Muirhead W, Oyesiku NM, Schwartz TH, Sinha S, Stoyanov D, Syro LV, Tsermoulas G, Williams A, Winder MJ, Zada G, Laws ER.
PMID: 34231079
Pituitary. 2021 Dec;24(6):839-853. doi: 10.1007/s11102-021-01162-3. Epub 2021 Jul 06.

PURPOSE: Surgical workflow analysis seeks to systematically break down operations into hierarchal components. It facilitates education, training, and understanding of surgical variations. There are known educational demands and variations in surgical practice in endoscopic transsphenoidal approaches to pituitary adenomas....

Cite
Marcus HJ, Khan DZ, Borg A, et al. Pituitary society expert Delphi consensus: operative workflow in endoscopic transsphenoidal pituitary adenoma resection. Pituitary. 2021;24(6):839-853doi: 10.1007/s11102-021-01162-3.
Marcus, H. J., Khan, D. Z., Borg, A., Buchfelder, M., Cetas, J. S., Collins, J. W., Dorward, N. L., Fleseriu, M., Gurnell, M., Javadpour, M., Jones, P. S., Koh, C. H., Layard Horsfall, H., Mamelak, A. N., Mortini, P., Muirhead, W., Oyesiku, N. M., Schwartz, T. H., Sinha, S., Stoyanov, D., Syro, L. V., Tsermoulas, G., Williams, A., Winder, M. J., Zada, G., & Laws, E. R. (2021). Pituitary society expert Delphi consensus: operative workflow in endoscopic transsphenoidal pituitary adenoma resection. Pituitary, 24(6), 839-853. https://doi.org/10.1007/s11102-021-01162-3
Marcus, Hani J, et al. "Pituitary society expert Delphi consensus: operative workflow in endoscopic transsphenoidal pituitary adenoma resection." Pituitary vol. 24,6 (2021): 839-853. doi: https://doi.org/10.1007/s11102-021-01162-3
Marcus HJ, Khan DZ, Borg A, Buchfelder M, Cetas JS, Collins JW, Dorward NL, Fleseriu M, Gurnell M, Javadpour M, Jones PS, Koh CH, Layard Horsfall H, Mamelak AN, Mortini P, Muirhead W, Oyesiku NM, Schwartz TH, Sinha S, Stoyanov D, Syro LV, Tsermoulas G, Williams A, Winder MJ, Zada G, Laws ER. Pituitary society expert Delphi consensus: operative workflow in endoscopic transsphenoidal pituitary adenoma resection. Pituitary. 2021 Dec;24(6):839-853. doi: 10.1007/s11102-021-01162-3. Epub 2021 Jul 06. PMID: 34231079; PMCID: PMC8259776.
Copy Download .nbib Format: NLM
Predictors of health-related quality of life in patients with Crohn's disease receiving biological therapy.

Scandinavian journal of gastroenterology

Lundquist LR, Rasmussen B, Waldorff FB, Wehberg S, Kjeldsen J, Haastrup P.
PMID: 34493132
Scand J Gastroenterol. 2021 Dec;56(12):1434-1441. doi: 10.1080/00365521.2021.1974086. Epub 2021 Sep 07.

BACKGROUND AND AIM: Health-related quality of life (HRQoL) is impaired in patients with Crohn's disease (CD). This study aimed to identify the impact of clinical disease activity on HRQoL in CD patients treated with biological agents.METHODS: Patients with moderate...

Cite
Lundquist LR, Rasmussen B, Waldorff FB, et al. Predictors of health-related quality of life in patients with Crohn's disease receiving biological therapy. Scand J Gastroenterol. 2021;56(12):1434-1441doi: 10.1080/00365521.2021.1974086.
Lundquist, L. R., Rasmussen, B., Waldorff, F. B., Wehberg, S., Kjeldsen, J., & Haastrup, P. (2021). Predictors of health-related quality of life in patients with Crohn's disease receiving biological therapy. Scandinavian journal of gastroenterology, 56(12), 1434-1441. https://doi.org/10.1080/00365521.2021.1974086
Lundquist, Lasse R, et al. "Predictors of health-related quality of life in patients with Crohn's disease receiving biological therapy." Scandinavian journal of gastroenterology vol. 56,12 (2021): 1434-1441. doi: https://doi.org/10.1080/00365521.2021.1974086
Lundquist LR, Rasmussen B, Waldorff FB, Wehberg S, Kjeldsen J, Haastrup P. Predictors of health-related quality of life in patients with Crohn's disease receiving biological therapy. Scand J Gastroenterol. 2021 Dec;56(12):1434-1441. doi: 10.1080/00365521.2021.1974086. Epub 2021 Sep 07. PMID: 34493132.
Copy Download .nbib Format: NLM
Pilot investigation on the dose-dependent impact of irradiation on primary human alveolar osteoblasts in vitro.

Scientific reports

Amler AK, Schlauch D, Tüzüner S, Thomas A, Neckel N, Tinhofer I, Heiland M, Lauster R, Kloke L, Stromberger C, Nahles S.
PMID: 34615948
Sci Rep. 2021 Oct 06;11(1):19833. doi: 10.1038/s41598-021-99323-8.

Radiotherapy of head and neck squamous cell carcinoma can lead to long-term complications like osteoradionecrosis, resulting in severe impairment of the jawbone. Current standard procedures require a 6-month wait after irradiation before dental reconstruction can begin. A comprehensive characterization...

Cite
Amler AK, Schlauch D, Tüzüner S, et al. Pilot investigation on the dose-dependent impact of irradiation on primary human alveolar osteoblasts in vitro. Sci Rep. 2021;11(1):19833doi: 10.1038/s41598-021-99323-8.
Amler, A. K., Schlauch, D., Tüzüner, S., Thomas, A., Neckel, N., Tinhofer, I., Heiland, M., Lauster, R., Kloke, L., Stromberger, C., & Nahles, S. (2021). Pilot investigation on the dose-dependent impact of irradiation on primary human alveolar osteoblasts in vitro. Scientific reports, 11(1), 19833. https://doi.org/10.1038/s41598-021-99323-8
Amler, Anna-Klara, et al. "Pilot investigation on the dose-dependent impact of irradiation on primary human alveolar osteoblasts in vitro." Scientific reports vol. 11,1 (2021): 19833. doi: https://doi.org/10.1038/s41598-021-99323-8
Amler AK, Schlauch D, Tüzüner S, Thomas A, Neckel N, Tinhofer I, Heiland M, Lauster R, Kloke L, Stromberger C, Nahles S. Pilot investigation on the dose-dependent impact of irradiation on primary human alveolar osteoblasts in vitro. Sci Rep. 2021 Oct 06;11(1):19833. doi: 10.1038/s41598-021-99323-8. PMID: 34615948; PMCID: PMC8494843.
Copy Download .nbib Format: NLM
The tipping point of antenatal engagement: A qualitative grounded theory in Tanzania and Zambia.

Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives

Laisser R, Woods R, Bedwell C, Kasengele C, Nsemwa L, Kimaro D, Kuzenza F, Lyangenda K, Shayo H, Tuwele K, Wakasiaka S, Ringia P, Lavender T.
PMID: 34775355
Sex Reprod Healthc. 2021 Oct 27;31:100673. doi: 10.1016/j.srhc.2021.100673. Epub 2021 Oct 27.

BACKGROUND: Effective antenatal care is fundamental to the promotion of positive maternal and new-born outcomes. International guidance recommends an initial visit in the first trimester of pregnancy, with a minimum of four antenatal visits in total: the optimum schedule...

Cite
Laisser R, Woods R, Bedwell C, et al. The tipping point of antenatal engagement: A qualitative grounded theory in Tanzania and Zambia. Sex Reprod Healthc. 2021;31:100673doi: 10.1016/j.srhc.2021.100673.
Laisser, R., Woods, R., Bedwell, C., Kasengele, C., Nsemwa, L., Kimaro, D., Kuzenza, F., Lyangenda, K., Shayo, H., Tuwele, K., Wakasiaka, S., Ringia, P., & Lavender, T. (2021). The tipping point of antenatal engagement: A qualitative grounded theory in Tanzania and Zambia. Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives, 31100673. https://doi.org/10.1016/j.srhc.2021.100673
Laisser, Rose, et al. "The tipping point of antenatal engagement: A qualitative grounded theory in Tanzania and Zambia." Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives vol. 31 (2021): 100673. doi: https://doi.org/10.1016/j.srhc.2021.100673
Laisser R, Woods R, Bedwell C, Kasengele C, Nsemwa L, Kimaro D, Kuzenza F, Lyangenda K, Shayo H, Tuwele K, Wakasiaka S, Ringia P, Lavender T. The tipping point of antenatal engagement: A qualitative grounded theory in Tanzania and Zambia. Sex Reprod Healthc. 2021 Oct 27;31:100673. doi: 10.1016/j.srhc.2021.100673. Epub 2021 Oct 27. PMID: 34775355.
Copy Download .nbib Format: NLM
Predicting disease progression in behavioral variant frontotemporal dementia.

Alzheimer's & dementia (Amsterdam, Netherlands)

Anderl-Straub S, Lausser L, Lombardi J, Uttner I, Fassbender K, Fliessbach K, Huppertz HJ, Jahn H, Kornhuber J, Obrig H, Schneider A, Semler E, Synofzik M, Danek A, Prudlo J, Kassubek J, Landwehrmeyer B, Lauer M, Volk AE, Wiltfang J, Diehl-Schmid J, Ludolph AC, Schroeter ML, Kestler HA, Otto M.
PMID: 35005196
Alzheimers Dement (Amst). 2021 Dec 31;13(1):e12262. doi: 10.1002/dad2.12262. eCollection 2021.

INTRODUCTION: The behavioral variant of frontotemporal dementia (bvFTD) is a rare neurodegenerative disease. Reliable predictors of disease progression have not been sufficiently identified. We investigated multivariate magnetic resonance imaging (MRI) biomarker profiles for their predictive value of individual decline.METHODS:...

Cite
Anderl-Straub S, Lausser L, Lombardi J, et al. Predicting disease progression in behavioral variant frontotemporal dementia. Alzheimers Dement (Amst). 2021;13(1):e12262doi: 10.1002/dad2.12262.
Anderl-Straub, S., Lausser, L., Lombardi, J., Uttner, I., Fassbender, K., Fliessbach, K., Huppertz, H. J., Jahn, H., Kornhuber, J., Obrig, H., Schneider, A., Semler, E., Synofzik, M., Danek, A., Prudlo, J., Kassubek, J., Landwehrmeyer, B., Lauer, M., Volk, A. E., Wiltfang, J., Diehl-Schmid, J., Ludolph, A. C., Schroeter, M. L., Kestler, H. A., Otto, M. (2021). Predicting disease progression in behavioral variant frontotemporal dementia. Alzheimer's & dementia (Amsterdam, Netherlands), 13(1), e12262. https://doi.org/10.1002/dad2.12262
Anderl-Straub, Sarah, et al. "Predicting disease progression in behavioral variant frontotemporal dementia." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 13,1 (2021): e12262. doi: https://doi.org/10.1002/dad2.12262
Anderl-Straub S, Lausser L, Lombardi J, Uttner I, Fassbender K, Fliessbach K, Huppertz HJ, Jahn H, Kornhuber J, Obrig H, Schneider A, Semler E, Synofzik M, Danek A, Prudlo J, Kassubek J, Landwehrmeyer B, Lauer M, Volk AE, Wiltfang J, Diehl-Schmid J, Ludolph AC, Schroeter ML, Kestler HA, Otto M. Predicting disease progression in behavioral variant frontotemporal dementia. Alzheimers Dement (Amst). 2021 Dec 31;13(1):e12262. doi: 10.1002/dad2.12262. eCollection 2021. PMID: 35005196; PMCID: PMC8719425.
Copy Download .nbib Format: NLM
Current concepts in the management of periodontitis.

International dental journal

Kwon T, Lamster IB, Levin L.
PMID: 33277943
Int Dent J. 2020 Dec 05; doi: 10.1111/idj.12630. Epub 2020 Dec 05.

Periodontitis is a common disorder affecting >40% of adults in the United States. Globally, the severe form of the disease has a prevalence of 11%. In advanced cases, periodontitis leads to tooth loss and reduced quality of life. The...

Cite
Kwon T, Lamster IB, Levin L. Current concepts in the management of periodontitis. Int Dent J. 2020;doi: 10.1111/idj.12630.
Kwon, T., Lamster, I. B., & Levin, L. (2020). Current concepts in the management of periodontitis. International dental journal, . https://doi.org/10.1111/idj.12630
Kwon, TaeHyun, et al. "Current concepts in the management of periodontitis." International dental journal vol. (2020). doi: https://doi.org/10.1111/idj.12630
Kwon T, Lamster IB, Levin L. Current concepts in the management of periodontitis. Int Dent J. 2020 Dec 05; doi: 10.1111/idj.12630. Epub 2020 Dec 05. PMID: 33277943.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in oncology

Ombredane AS, Silva VRP, Andrade LR, Pinheiro WO, Simonelly M, Oliveira JV, Pinheiro AC, Gonçalves GF, Felice GJ, Garcia MP, Campos PM, Luz GVS, Joanitti GA.
PMID: 33767985
Front Oncol. 2021 Mar 09;11:612903. doi: 10.3389/fonc.2021.612903. eCollection 2021.

Breast cancer is one of the most prevalent types of malignant tumors in the world, resulting in a high incidence of death. The development of new molecules and technologies aiming to apply more effective and safer therapy strategies has...

Cite
Ombredane AS, Silva VRP, Andrade LR, et al. . Front Oncol. 2021;11:612903doi: 10.3389/fonc.2021.612903.
Ombredane, A. S., Silva, V. R. P., Andrade, L. R., Pinheiro, W. O., Simonelly, M., Oliveira, J. V., Pinheiro, A. C., Gonçalves, G. F., Felice, G. J., Garcia, M. P., Campos, P. M., Luz, G. V. S., & Joanitti, G. A. (2021). . Frontiers in oncology, 11612903. https://doi.org/10.3389/fonc.2021.612903
Ombredane, Alicia S, et al. "." Frontiers in oncology vol. 11 (2021): 612903. doi: https://doi.org/10.3389/fonc.2021.612903
Ombredane AS, Silva VRP, Andrade LR, Pinheiro WO, Simonelly M, Oliveira JV, Pinheiro AC, Gonçalves GF, Felice GJ, Garcia MP, Campos PM, Luz GVS, Joanitti GA. . Front Oncol. 2021 Mar 09;11:612903. doi: 10.3389/fonc.2021.612903. eCollection 2021. PMID: 33767985; PMCID: PMC7986721.
Copy Download .nbib Format: NLM
Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial.

Journal of asthma and allergy

Corren J, Saini SS, Gagnon R, Moss MH, Sussman G, Jacobs J, Laws E, Chung ES, Constant T, Sun Y, Maloney J, Hamilton JD, Ruddy M, Wang CQ, O'Brien MP.
PMID: 34429614
J Asthma Allergy. 2021 Aug 16;14:1045-1063. doi: 10.2147/JAA.S318892. eCollection 2021.

BACKGROUND: Subcutaneous immunotherapy (SCIT) has been proven as an effective therapy against some allergens for seasonal allergic rhinitis (SAR) patients unresponsive to intranasal corticosteroids and/or antihistamines but carries risk of systemic allergic reactions. Dupilumab blocks the shared receptor component...

Cite
Corren J, Saini SS, Gagnon R, et al. Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial. J Asthma Allergy. 2021;14:1045-1063doi: 10.2147/JAA.S318892.
Corren, J., Saini, S. S., Gagnon, R., Moss, M. H., Sussman, G., Jacobs, J., Laws, E., Chung, E. S., Constant, T., Sun, Y., Maloney, J., Hamilton, J. D., Ruddy, M., Wang, C. Q., & O'Brien, M. P. (2021). Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial. Journal of asthma and allergy, 141045-1063. https://doi.org/10.2147/JAA.S318892
Corren, Jonathan, et al. "Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial." Journal of asthma and allergy vol. 14 (2021): 1045-1063. doi: https://doi.org/10.2147/JAA.S318892
Corren J, Saini SS, Gagnon R, Moss MH, Sussman G, Jacobs J, Laws E, Chung ES, Constant T, Sun Y, Maloney J, Hamilton JD, Ruddy M, Wang CQ, O'Brien MP. Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial. J Asthma Allergy. 2021 Aug 16;14:1045-1063. doi: 10.2147/JAA.S318892. eCollection 2021. PMID: 34429614; PMCID: PMC8379710.
Copy Download .nbib Format: NLM
Showing 589 to 260 of 260 entries